Blood Screening Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018-2026

1. Blood Screening Market - Size, Share, Growth, Blood Screening Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Outlook, and Opportunity Analysis, 2018-2026 A blood screening is the process of laboratory testing for extracting blood prior to blood transfusion. The test is performed to ensure that recipients receive safe blood products. There are various blood screening procedures for donated blood to ensure that blood units are safe. Blood samples collected during donation undergo laboratory screening for Transfusion-Transmissible Infections (TTIs). In screening technique, blood sample is tested for evidence of certain infectious disease pathogens such as hepatitis B and C viruses and human immunodeficiency virus (HIV). There are different types of assay used for blood screening, which include Immunoassays (IAs) and nucleic acid amplification technology (NAT) assays. Immunoassays (IAs) is further subcategorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays, and rapid/simple single-use assays (rapid tests). Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2409 Increasing demand for NAT over ELISA (enzyme-linked immunosorbent assay) test due to high sensitivity and specificity for viral nucleic acid is boosting growth of the blood screening market. For instance, in 2018, Grifols received approval from the U.S. Food & Drug Administration (FDA) for two blood screening assays- Procleix Ultrio Elite and Procleix WNV. Both assays run on the fully automated NAT blood screening platform: Procleix Panther system. The Procleix Panther system with these assays helps blood centers to efficiently screen for infectious diseases and eliminates the need of batch processing. Increasing number of blood donations campaigns by the government, blood donor agencies, and NGO’s are expected to propel growth of the blood screening market. For instance, according to the WHO reported data in June 2017, around 112.5 million blood donations are collected globally and around half of these are collected in high-income countries, highlighting 19% of the world’s population. Moreover, increase in initiatives by the government to create awareness among the people regarding safety of the donated blood is expected to drive growth of the market. For

2. instance, in 2014, World Health Organization (WHO) recommended to establish a national blood system with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation that can provide sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients. Report includes chapters which deeply display the following deliverable about industry : • Blood Screening Market Research Objective and Assumption • Blood Screening Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Blood Screening Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Blood Screening Market, By Regions • Blood Screening Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Blood Screening Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Blood Screening Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Blood Screening Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key Player operating in the blood screening market include Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary of Danaher Corporation) and Becton, Dickinson and Company. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2409

3. Blood Screening Market- Taxonomy By Technology: Nucleic acid amplification technology (NAT) ELISA Immunoassays (IAs) Next-Generation Sequencing (NGS) Western Blotting • • • • • By Product Type Reagents & Kits Instruments • • By End User: Hospital Blood Banks Diagnostics Laboratory • • • By Region North America Europe Asia Pacific Latin America Middle East Africa • • • • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights

4. 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com